Status:

COMPLETED

Triamcinolone Acetonide as an Adjuvant to Pre-emptive Scalp Infiltration for Relief of Post-craniotomy Pain in Adults

Lead Sponsor:

Beijing Tiantan Hospital

Conditions:

Pain, Postoperative

Eligibility:

All Genders

18-64 years

Phase:

PHASE4

Brief Summary

Pain is common for the first 2 days after major craniotomy. A majority of patients would suffer from moderate-to-severe postoperative pain after undergoing craniotomy. Inadequate analgesia induced sym...

Eligibility Criteria

Inclusion

  • Patients scheduled for elective craniotomy for resection of tumour under general anaesthesia;
  • American Society of Anesthesiologists (ASA) physical status of I ,II or III;
  • Participates with an anticipated fully recovery within 2 hours postoperatively;

Exclusion

  • History of craniotomy;
  • Expected delayed extubation or no plan to extubate;
  • Participants who cannot use a patient-controlled analgesia (PCA) device;
  • Participants who cannot understand the instructions of a numeral rating scale (NRS) 35 before surgery;
  • Extreme body mass index (BMI) (\< 15 or \> 35);
  • Allergy to opioids, triamcinolone acetonide or ropivacaine;
  • History of excessive alcohol or drug abuse, chronic opioid use (more than 2 weeks), or use of drugs with confirmed or suspected sedative or analgesic effects;
  • History of psychiatric disorders, uncontrolled epilepsy or chronic headache;
  • Pregnant or at breastfeeding;
  • Symptomatic cardiopulmonary, renal, or liver dysfunction or history of diabetes;
  • Preoperative Glasgow Coma Scale\< 15;
  • Suspicion of intracranial hypertension;
  • Peri-incisional infection;
  • Participants who have received radiation therapy and chemotherapy preoperatively or with a high probability to require a postoperative radiation therapy and chemotherapy according to the preoperative imaging.

Key Trial Info

Start Date :

October 7 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2023

Estimated Enrollment :

110 Patients enrolled

Trial Details

Trial ID

NCT06069804

Start Date

October 7 2023

End Date

December 31 2023

Last Update

April 3 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Beijing Tiantan Hospital

Beijing, Beijing Municipality, China, 100050